FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065793 [Registered on: 16/04/2024] Trial Registered Prospectively
Last Modified On: 12/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   It is a single arm clinical study to see the efficacy of Darvyadi Kwath drug (Ayurvedic formulation)in patients suffering from neuropathic symptoms caused due to chronocity of Diabetes Mellitus disease.  
Scientific Title of Study   A Single Arm clinical study to evaluate the efficacy of Darvyadi Kwath in Diabetic Polyneuropathy. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Swapnil Balasaheb Kedar 
Designation  PG Scholar Kayachikitsa 
Affiliation  Dr D Y Patil College Of Ayurved and Research Centre 
Address  Dr D Y Patil College of Ayurved and Research Centre Sant Tukaram Nagar Pimpri Pune Maharashtra 411018

Pune
MAHARASHTRA
411018
India 
Phone  9168448887  
Fax    
Email  swapnilkedar0@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhijit Shekhar 
Designation  Assiciate Professor and Phd Scholar 
Affiliation  Dr. D. Y. Patil College of Ayurved and Research Centre 
Address  Dr D Y Patil College of Ayurved and Research Centre Sant Tukaram Nagar Pimpri Pune

Pune
MAHARASHTRA
411018
India 
Phone  9168448887  
Fax    
Email  abhijitshekhar00@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abhijit Shekhar 
Designation  Associates Professor and Phd Scholar 
Affiliation  Dr. D. Y. Patil College of Ayurved and Research Centre 
Address  Dr D Y Patil College of Ayurved and Research Centre Sant Tukaram Nagar Pimpri Pune
Dr D Y Patil College of Ayurved and Research Centre Sant Tukaram Nagar Pimpri Pune
Pune
MAHARASHTRA
411018
India 
Phone  9168448887  
Fax    
Email  abhijitshekhar00@gmail.com  
 
Source of Monetary or Material Support  
Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018 
 
Primary Sponsor  
Name  Dr Swapnil Balasaheb Kedar 
Address  Dr D Y Patil College of Ayurved and Research Centre Sant Tukaram Nagar Pimpri Pune Maharashtra 411018 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SWAPNIL BALASAHEB KEDAR  Dr D Y Patil College Of Ayurved and Research Centre  kayachikitsa department,5 no opd ,Dr D Y patil college of Ayurved and Research Centre,pimpri pune
Pune
MAHARASHTRA 
09168448887

swapnilkedar0@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr DYPCA and RC Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E114||Type 2 diabetes mellitus with neurological complications. Ayurveda Condition: PRAMEHA-UPADRAVAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Darvyadi Kwath, Reference: Charak Chikitsa chapter no 6 Prameha shlok 26th, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 28 Days, anupAna/sahapAna: No, Additional Information: Darvyadi Kwath will be given to the patient of Diabetic Polyneuropathy.
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  A known Diabetic on treatment.
Patient who are not taking any medications for Diabetic Polyneuropathy And having symptoms of Diabetic Polyneuropathy
 
 
ExclusionCriteria 
Details  1. Pregnant lactating women.
2. Patients with pulmonary tuberculosis, cardiac complications, Renal complications, sciatica, cord compression, Immunocompromised patients, malignancies.
3. Vitamin B12 deficiency.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
efficacy of Darvyadi Kwath will be assessed over the 28 days by objective parameters.   28 Days study.
Follow up on 14th and 28th days 
 
Secondary Outcome  
Outcome  TimePoints 
To study the Distal Symmetric Polyneuropathy in Diabetes under the subjective
measurement of Toronto Clinical scoring scale. 
28 Days study.
Follow up on 14th & 28th day. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   25/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   TO STUDY EFFECT OF DARVYADI KWATH GIVEN  40 ML TWICE A DAY ORALLY ON 30 PATIENTS WHO HAVING SYMPTOMS OF DIABETIC  POLYNEUROPATHY I.E. TINGLING SENSATION,BURNING SENSATION,PAIN,NUMBNESS ETC WITHIN 28 DAYS WITH TWO FOLLOW UPSDUE TO CHRONIC ILLNESS OF DIABETES MELLITUS.FINAL CONCLUSION WILL BE DRAWN ON THE BASIS OF STATISTICAL METHODS. 
Close